120 related articles for article (PubMed ID: 31738894)
1. SK channel activation potentiates auranofin-induced cell death in glio- and neuroblastoma cells.
Krabbendam IE; Honrath B; Bothof L; Silva-Pavez E; Huerta H; Peñaranda Fajardo NM; Dekker F; Schmidt M; Culmsee C; César Cárdenas J; Kruyt F; Dolga AM
Biochem Pharmacol; 2020 Jan; 171():113714. PubMed ID: 31738894
[TBL] [Abstract][Full Text] [Related]
2. SK2 channels regulate mitochondrial respiration and mitochondrial Ca
Honrath B; Matschke L; Meyer T; Magerhans L; Perocchi F; Ganjam GK; Zischka H; Krasel C; Gerding A; Bakker BM; Bünemann M; Strack S; Decher N; Culmsee C; Dolga AM
Cell Death Differ; 2017 May; 24(5):761-773. PubMed ID: 28282037
[TBL] [Abstract][Full Text] [Related]
3. SK channel activation modulates mitochondrial respiration and attenuates neuronal HT-22 cell damage induced by H2O2.
Richter M; Nickel C; Apel L; Kaas A; Dodel R; Culmsee C; Dolga AM
Neurochem Int; 2015 Feb; 81():63-75. PubMed ID: 25576183
[TBL] [Abstract][Full Text] [Related]
4. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity.
Bury M; Girault A; Mégalizzi V; Spiegl-Kreinecker S; Mathieu V; Berger W; Evidente A; Kornienko A; Gailly P; Vandier C; Kiss R
Cell Death Dis; 2013 Mar; 4(3):e561. PubMed ID: 23538442
[TBL] [Abstract][Full Text] [Related]
5. Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
Van Loenhout J; Freire Boullosa L; Quatannens D; De Waele J; Merlin C; Lambrechts H; Lau HW; Hermans C; Lin A; Lardon F; Peeters M; Bogaerts A; Smits E; Deben C
Cells; 2021 Oct; 10(11):. PubMed ID: 34831159
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
Skaga E; Skaga IØ; Grieg Z; Sandberg CJ; Langmoen IA; Vik-Mo EO
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1495-1507. PubMed ID: 31028540
[TBL] [Abstract][Full Text] [Related]
7. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
8. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Kast RE; Karpel-Massler G; Halatsch ME
Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
[TBL] [Abstract][Full Text] [Related]
9. Induction of Mitochondrial Dysfunction and Oxidative Damage by Antibiotic Drug Doxycycline Enhances the Responsiveness of Glioblastoma to Chemotherapy.
Tan Q; Yan X; Song L; Yi H; Li P; Sun G; Yu D; Li L; Zeng Z; Guo Z
Med Sci Monit; 2017 Aug; 23():4117-4125. PubMed ID: 28842551
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
[TBL] [Abstract][Full Text] [Related]
11. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
Cox AG; Brown KK; Arner ES; Hampton MB
Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312
[TBL] [Abstract][Full Text] [Related]
12. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
Hwang-Bo H; Jeong JW; Han MH; Park C; Hong SH; Kim GY; Moon SK; Cheong J; Kim WJ; Yoo YH; Choi YH
Gen Physiol Biophys; 2017 Apr; 36(2):117-128. PubMed ID: 28218611
[TBL] [Abstract][Full Text] [Related]
13. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug.
Kast RE
Cent Eur Neurosurg; 2010 Aug; 71(3):139-42. PubMed ID: 20127591
[No Abstract] [Full Text] [Related]
15. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
[TBL] [Abstract][Full Text] [Related]
16. SK channel activation is neuroprotective in conditions of enhanced ER-mitochondrial coupling.
Honrath B; Krabbendam IE; IJsebaart C; Pegoretti V; Bendridi N; Rieusset J; Schmidt M; Culmsee C; Dolga AM
Cell Death Dis; 2018 May; 9(6):593. PubMed ID: 29789578
[TBL] [Abstract][Full Text] [Related]
17. Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative.
Rigobello MP; Scutari G; Boscolo R; Bindoli A
Br J Pharmacol; 2002 Aug; 136(8):1162-8. PubMed ID: 12163349
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines.
Abdulkareem ZA; Gee JM; Cox CD; Wann KT
Br J Pharmacol; 2016 Jan; 173(1):177-90. PubMed ID: 26454020
[TBL] [Abstract][Full Text] [Related]
19. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
Liu JJ; Liu Q; Wei HL; Yi J; Zhao HS; Gao LP
Pharmazie; 2011 Jun; 66(6):440-4. PubMed ID: 21699084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
